Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Jiang Fu
Low peak expiratory flow and subsequent first self-report of recognized lung disease: Person-disjoint replication and spirometric benchmarking in HRS and ELSA
Associations with first disease report were estimated using repeated-window or discrete-time logistic regression. HRS models were fitted as binomial generalized linear models, and ELSA models maximized the corresponding logistic likelihood. Sandwich standard errors were clustered by participant in both cohorts. The systemic model was the principal adjusted analysis; estimates from earlier adjustment sets were not interpreted as attenuation because their complete-record samples differed.
Accuracy of Pterygoid Implant Placement With Augmented and Mixed Reality Navigation: An In Vitro Study
1 Introduction Advances in digital dentistry have fundamentally reshaped dental implant treatment workflows in recent years (Mangano 2021; Murthy et al. 2024). The integration of cone-beam computed tomography (CBCT) and intraoral scanning (IOS) provides detailed 3D anatomical data for computer-assisted implant surgery (CAIS) (Shi et al. 2023; Zheng et al. 2025).
Advances in neurotensin receptor 1-targeted molecular probes for tumor molecular imaging and therapy
Abstract Neurotensin receptor 1 (NTS1) is a high-affinity G protein-coupled receptor (GPCR) for the endogenous peptide neurotensin (NT). NTS1 is overexpressed across multiple malignancies and is an important target for precision theranostics.
The gastrin-releasing peptide receptor in oncology: a comprehensive review of recent advances in targeted radionuclide theranostics
Abstract The gastrin-releasing peptide receptor (GRPR) is aberrantly expressed in several malignancies, including prostate cancer, breast cancer, lung cancer, and gastrointestinal stromal tumors, making it an important target for molecular imaging and targeted radionuclide therapy. In recent years, advances in radioligand design, radionuclide selection, and theranostic concepts have substantially promoted the development of GRPR-mediated oncologic applications in nuclear medicine.
Radionuclide theranostics: advances and clinical applications in lung cancer
Abstract Lung cancer remains a leading cause of global cancer deaths, underscoring the urgent need for more accurate diagnostic and treatment approaches. Radionuclide theranostics has rapidly emerged as a paradigm that couples molecular imaging with targeted internal irradiation, enabling personalized cancer care. This review provides a systematic overview of radionuclide theranostics in lung cancer.
Development and usability evaluation of a patient journey-based mHealth intervention for esophageal cancer patients: a three-phase protocol
1 Introduction Esophageal cancer (EC) is an aggressive malignancy and ranks as the sixth leading cause of cancer-related mortality worldwide (1). In 2020, an estimated 604,000 new cases and 544,000 deaths were reported globally (2), with China accounting for more than half of the total burden (3, 4). Despite progress in multimodal treatment, including surgery, chemotherapy, and radiotherapy (5), the overall prognosis remains poor, with a 5-year survival rate of approximately 30% (6).
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Jiang
Contact Jiang, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack